The State of Texas has sued pharmaceutical firm Eli Lilly & Firm Inc., alleging the corporate engaged in improper practices to affect medical suppliers to prescribe its most commercially profitable medication, together with the GLP-1 medicines Mounjaro and Zepbound, that are indicated for weight reduction and diabetes administration.
Trending
- Ben & Jerry Built the Brand. Magnum’s IPO Ignores That at Its Peril.
- Nanlite launches miro 30c and 60c full-color panel lights
- When shopping delivers a moral dilemma | Letters
- ‘It should be gay Disneyland’: the struggle to revitalise Sydney’s Oxford Street without selling its soul | Sydney
- I Bet You’ve Never Broken a Piece of Camera Gear as Expensive as This Shattered Lens
- Woman admits UK bitcoin fraud charges after ‘world’s largest’ crypto seizure | Crime
- Is Milan the Best-Dressed Place in the World?
- Adobe’s new Premiere Pro app will have you purring into your iPhone
Texas Sues Eli Lilly: ‘Big Pharma Compromised Medical Decision-Making’
